RAPID MICRO BIOSYSTEMS, INC.
Datakwaliteit: 100%
RPID
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
€ 2,12
€ 0,00
(0,00%)
Marktkapitalisatie: 97,75 M
Prijs
€ 2,15
Marktkapitalisatie
97,75 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 9,65% annually over 5 years — modest growth
Debt/Equity of 0,42 — conservative balance sheet
Negative free cash flow of -31,91 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,09%
Capital efficient — spends only 2,53% of revenue on capex
Groei
Revenue Growth (5Y)
9,65%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)19,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-95,32%
Onder sectorgemiddelde (-54,01%)
ROIC-58,94%
Net Margin-140,30%
Op. Margin-141,10%
Veiligheid
Debt / Equity
0,42
Boven sectorgemiddelde (0,30)
Current Ratio4,23
Interest Coverage-43,48
Waardering
PE (TTM|NTM)
-2,07 | -2,57
Onder sectorgemiddelde (-1,49)
P/B Ratio2,20
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,1 | -1,5 |
| P/B | 2,2 | 1,6 |
| ROE % | -95,3 | -54,0 |
| Net Margin % | -140,3 | -41,5 |
| Rev Growth 5Y % | 9,7 | 1,8 |
| D/E | 0,4 | 0,3 |
Koersdoel Analisten
3 analisten
Buy
Huidig
€ 2,12
Koersdoel
€ 8,00
€ 8,00
€ 8,00
€ 8,00
Vooruitzicht
Forward K/W
-2,57
Forward WPA
-€ 0,82
Omzet Sch.
46,45 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,82
-€ 0,91 – -€ 0,74
|
46,45 M | 3 |
| FY2026 |
-€ 0,92
-€ 0,96 – -€ 0,89
|
39,23 M | 3 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,23
-€ 0,26 – -€ 0,20
|
7,68 M | 3 |
| 2026 Q1 |
-€ 0,25
-€ 0,28 – -€ 0,21
|
7,60 M | 3 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,23 | -€ 0,28 | -23,5% |
| Q32025 | -€ 0,25 | -€ 0,26 | -6,1% |
| Q22025 | -€ 0,25 | -€ 0,27 | -6,6% |
| Q12025 | -€ 0,27 | -€ 0,26 | +3,7% |
ETFs Holding This Stock
0,00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,74% | Revenue Growth (3Y) | 22,13% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33,59 M | Net Income (TTM) | -47,12 M |
| ROE | -95,32% | ROA | -58,91% |
| Gross Margin | N/A | Operating Margin | -141,10% |
| Net Margin | -140,30% | Free Cash Flow (TTM) | -31,91 M |
| ROIC | -58,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,42 | Current Ratio | 4,23 |
| Interest Coverage | -43,48 | Asset Turnover | 0,42 |
| Working Capital | 53,40 M | Tangible Book Value | 44,33 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,07 | Forward P/E | -2,57 |
| P/B Ratio | 2,20 | P/S Ratio | 2,91 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,10 | Fwd Earnings Yield | N/A |
| FCF Yield | -32,65% | ||
| Market Cap | 97,75 M | Enterprise Value | 97,63 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,05 | Revenue / Share | 0,74 |
| FCF / Share | -0,70 | OCF / Share | -0,68 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 2,53% | FCF Conversion | 67,72% |
| SBC-Adj. FCF | -36,25 M | Growth Momentum | 10,09 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33,59 M | 28,05 M | 22,52 M | 17,13 M | 23,23 M |
| Net Income | -47,12 M | -46,89 M | -52,47 M | -60,81 M | -73,52 M |
| EPS (Diluted) | -1,05 | -1,08 | -1,22 | -1,43 | -3,94 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -47,39 M | -49,92 M | -56,56 M | -63,22 M | -47,23 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13,60 M | 14,60 M | 12,82 M | 12,87 M | 9,78 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 3,25 M | 3,36 M | 3,11 M | 2,84 M | 1,53 M |
| Interest Expense | 1,09 M | — | 4,21 M | 1,78 M | 2,65 M |
| Income Tax | 40.000,0 | 22.000,0 | 31.000,0 | -576.000,0 | 91.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 74,85 M | 98,17 M | 143,45 M | 190,65 M | 241,17 M |
| Total Liabilities | 41,65 M | 22,82 M | 25,46 M | 26,48 M | 20,19 M |
| Shareholders' Equity | 33,21 M | 75,35 M | 117,99 M | 164,17 M | 220,98 M |
| Total Debt | 18,90 M | — | — | 0,0 | 0,0 |
| Cash & Equivalents | 20,03 M | 16,91 M | 24,29 M | 27,06 M | 178,39 M |
| Current Assets | 61,17 M | 80,92 M | 120,42 M | 138,58 M | 218,12 M |
| Current Liabilities | 18,49 M | 17,57 M | 18,99 M | 19,05 M | 18,17 M |
{"event":"ticker_viewed","properties":{"ticker":"RPID","listing_kind":"stock","pathname":"/stocks/rpid","exchange":"NASDAQ","country":"US"}}